Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Saimiri | 67 | 2024 | 337 | 3.970 |
Why?
|
Behavior, Animal | 39 | 2024 | 1866 | 3.930 |
Why?
|
Discrimination Learning | 27 | 2021 | 276 | 3.590 |
Why?
|
Cocaine | 41 | 2021 | 945 | 2.850 |
Why?
|
Methamphetamine | 13 | 2021 | 166 | 2.540 |
Why?
|
Conditioning, Operant | 22 | 2021 | 306 | 2.220 |
Why?
|
Nicotine | 8 | 2019 | 682 | 2.160 |
Why?
|
Receptor, Cannabinoid, CB1 | 10 | 2020 | 138 | 2.090 |
Why?
|
Receptors, Dopamine D1 | 20 | 2007 | 276 | 2.060 |
Why?
|
Central Nervous System Stimulants | 14 | 2024 | 1167 | 1.710 |
Why?
|
Nicotinic Agonists | 5 | 2021 | 266 | 1.620 |
Why?
|
Dopamine Agonists | 17 | 2012 | 346 | 1.590 |
Why?
|
Dopamine Agents | 9 | 2014 | 186 | 1.570 |
Why?
|
Self Administration | 31 | 2024 | 386 | 1.560 |
Why?
|
Dose-Response Relationship, Drug | 59 | 2024 | 10723 | 1.430 |
Why?
|
Behavior, Addictive | 7 | 2019 | 423 | 1.430 |
Why?
|
Dopamine Uptake Inhibitors | 12 | 2019 | 287 | 1.330 |
Why?
|
Benzazepines | 17 | 2018 | 308 | 1.280 |
Why?
|
Substance Withdrawal Syndrome | 5 | 2019 | 626 | 1.270 |
Why?
|
Dopamine Antagonists | 12 | 2015 | 278 | 1.260 |
Why?
|
Cannabinoids | 6 | 2022 | 174 | 1.250 |
Why?
|
Receptors, Dopamine D2 | 13 | 2008 | 471 | 1.220 |
Why?
|
Macaca mulatta | 26 | 2024 | 2341 | 1.180 |
Why?
|
Reversal Learning | 4 | 2016 | 55 | 1.160 |
Why?
|
Analgesics, Opioid | 11 | 2024 | 3834 | 1.060 |
Why?
|
Naltrexone | 8 | 2024 | 319 | 1.030 |
Why?
|
Food | 7 | 2019 | 764 | 1.020 |
Why?
|
Substance-Related Disorders | 15 | 2019 | 4416 | 1.000 |
Why?
|
Receptors, Opioid, mu | 9 | 2024 | 165 | 0.930 |
Why?
|
Alkaloids | 4 | 2021 | 191 | 0.920 |
Why?
|
Receptors, Dopamine D4 | 2 | 2015 | 168 | 0.840 |
Why?
|
Animals | 142 | 2024 | 168730 | 0.830 |
Why?
|
2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine | 9 | 2006 | 50 | 0.830 |
Why?
|
Reinforcement Schedule | 17 | 2017 | 123 | 0.790 |
Why?
|
Buspirone | 2 | 2012 | 80 | 0.780 |
Why?
|
Drug Interactions | 18 | 2020 | 1416 | 0.760 |
Why?
|
Biology | 1 | 2023 | 293 | 0.740 |
Why?
|
Cocaine-Related Disorders | 9 | 2019 | 458 | 0.710 |
Why?
|
Arachidonic Acids | 4 | 2020 | 293 | 0.660 |
Why?
|
Amphetamine-Related Disorders | 2 | 2018 | 80 | 0.650 |
Why?
|
Pharmacology | 4 | 2021 | 97 | 0.640 |
Why?
|
Endocannabinoids | 3 | 2017 | 114 | 0.640 |
Why?
|
Piperidines | 7 | 2022 | 1662 | 0.630 |
Why?
|
Narcotic Antagonists | 6 | 2024 | 590 | 0.630 |
Why?
|
Drug-Seeking Behavior | 6 | 2024 | 45 | 0.620 |
Why?
|
Cannabidiol | 2 | 2021 | 123 | 0.610 |
Why?
|
Disulfiram | 1 | 2018 | 63 | 0.600 |
Why?
|
Cannabinol | 3 | 2017 | 9 | 0.590 |
Why?
|
Heroin | 1 | 2018 | 120 | 0.590 |
Why?
|
Cognition | 8 | 2024 | 7045 | 0.580 |
Why?
|
Analgesics, Non-Narcotic | 1 | 2021 | 367 | 0.570 |
Why?
|
Psychomotor Performance | 5 | 2021 | 1883 | 0.570 |
Why?
|
Neuroimmunomodulation | 1 | 2019 | 186 | 0.570 |
Why?
|
Pyrazoles | 7 | 2022 | 2031 | 0.560 |
Why?
|
Polyunsaturated Alkamides | 2 | 2017 | 29 | 0.560 |
Why?
|
Vaccines | 2 | 2016 | 841 | 0.540 |
Why?
|
Behavior | 5 | 2021 | 535 | 0.540 |
Why?
|
Nitrates | 1 | 2018 | 260 | 0.530 |
Why?
|
Behavioral Symptoms | 1 | 2018 | 187 | 0.530 |
Why?
|
Computers, Handheld | 1 | 2017 | 211 | 0.500 |
Why?
|
Drug Discovery | 1 | 2023 | 1063 | 0.500 |
Why?
|
Receptors, Dopamine D3 | 2 | 2012 | 106 | 0.480 |
Why?
|
Receptors, Nicotinic | 2 | 2018 | 494 | 0.470 |
Why?
|
Eating | 5 | 2018 | 1538 | 0.470 |
Why?
|
Touch | 2 | 2017 | 308 | 0.460 |
Why?
|
Smoke | 1 | 2016 | 243 | 0.450 |
Why?
|
Psychopharmacology | 3 | 2009 | 146 | 0.440 |
Why?
|
Wakefulness | 5 | 2024 | 1281 | 0.440 |
Why?
|
Dopamine | 7 | 2018 | 1583 | 0.420 |
Why?
|
Nucleus Accumbens | 4 | 2024 | 360 | 0.410 |
Why?
|
Adamantane | 2 | 2017 | 148 | 0.410 |
Why?
|
Selegiline | 3 | 2005 | 31 | 0.400 |
Why?
|
Reaction Time | 8 | 2021 | 2086 | 0.400 |
Why?
|
Psychology | 1 | 2014 | 354 | 0.390 |
Why?
|
Neuropsychological Tests | 3 | 2021 | 7119 | 0.380 |
Why?
|
Serotonin Receptor Agonists | 1 | 2012 | 151 | 0.380 |
Why?
|
Pyrrolidines | 6 | 2021 | 337 | 0.370 |
Why?
|
Male | 93 | 2024 | 363740 | 0.370 |
Why?
|
Biogenic Monoamines | 2 | 2010 | 50 | 0.360 |
Why?
|
Fentanyl | 3 | 2024 | 451 | 0.360 |
Why?
|
Tobacco Use Disorder | 2 | 2016 | 708 | 0.360 |
Why?
|
Blinking | 3 | 2007 | 135 | 0.350 |
Why?
|
Immunization | 1 | 2015 | 1218 | 0.350 |
Why?
|
Amphetamines | 2 | 2005 | 143 | 0.350 |
Why?
|
Cholinergic Agents | 1 | 2010 | 97 | 0.340 |
Why?
|
Nanotechnology | 1 | 2016 | 703 | 0.340 |
Why?
|
Pain Threshold | 1 | 2014 | 604 | 0.340 |
Why?
|
Receptors, Opioid | 5 | 2022 | 144 | 0.340 |
Why?
|
Anti-Anxiety Agents | 1 | 2012 | 402 | 0.340 |
Why?
|
Diuretics | 1 | 2012 | 612 | 0.320 |
Why?
|
Membrane Transport Proteins | 3 | 2017 | 1029 | 0.320 |
Why?
|
Psychotropic Drugs | 3 | 2021 | 881 | 0.320 |
Why?
|
GABA-A Receptor Agonists | 4 | 2003 | 85 | 0.310 |
Why?
|
Buprenorphine | 3 | 2019 | 665 | 0.310 |
Why?
|
Methylphenidate | 5 | 2024 | 480 | 0.310 |
Why?
|
Behavioral Research | 1 | 2008 | 52 | 0.300 |
Why?
|
Morphinans | 2 | 2023 | 27 | 0.300 |
Why?
|
Clinical Laboratory Techniques | 1 | 2013 | 747 | 0.300 |
Why?
|
Reward | 4 | 2024 | 980 | 0.290 |
Why?
|
Drug Tolerance | 6 | 2021 | 365 | 0.290 |
Why?
|
Opioid-Related Disorders | 5 | 2024 | 2176 | 0.290 |
Why?
|
Drug Partial Agonism | 2 | 2019 | 24 | 0.280 |
Why?
|
Receptors, Opioid, kappa | 5 | 2007 | 132 | 0.280 |
Why?
|
Pyridines | 4 | 2021 | 2887 | 0.270 |
Why?
|
Drug Delivery Systems | 2 | 2016 | 2210 | 0.270 |
Why?
|
Electroshock | 7 | 2012 | 120 | 0.270 |
Why?
|
Choice Behavior | 3 | 2015 | 846 | 0.270 |
Why?
|
Ligands | 8 | 2022 | 3273 | 0.260 |
Why?
|
Motor Activity | 3 | 2017 | 2705 | 0.260 |
Why?
|
Muscarinic Antagonists | 2 | 2021 | 133 | 0.260 |
Why?
|
Drug Synergism | 2 | 2021 | 1751 | 0.260 |
Why?
|
Piperazines | 6 | 2010 | 2546 | 0.250 |
Why?
|
Immunologic Factors | 1 | 2015 | 1584 | 0.250 |
Why?
|
Dextroamphetamine | 6 | 2010 | 132 | 0.250 |
Why?
|
Rats, Long-Evans | 2 | 2024 | 380 | 0.250 |
Why?
|
Quinolones | 1 | 2008 | 387 | 0.240 |
Why?
|
Benzofurans | 2 | 2007 | 140 | 0.240 |
Why?
|
Rats | 16 | 2024 | 23707 | 0.240 |
Why?
|
Oxycodone | 3 | 2024 | 144 | 0.240 |
Why?
|
Amphetamine | 4 | 2020 | 222 | 0.240 |
Why?
|
Disease Models, Animal | 6 | 2019 | 18289 | 0.230 |
Why?
|
Nicotinic Antagonists | 2 | 2018 | 90 | 0.230 |
Why?
|
Electroencephalography | 5 | 2024 | 6274 | 0.230 |
Why?
|
Motivation | 4 | 2024 | 2018 | 0.230 |
Why?
|
Membrane Transport Modulators | 1 | 2004 | 24 | 0.230 |
Why?
|
Nalbuphine | 2 | 2021 | 20 | 0.230 |
Why?
|
Receptors, Opioid, delta | 2 | 2022 | 47 | 0.220 |
Why?
|
N-Methyl-3,4-methylenedioxyamphetamine | 2 | 2021 | 69 | 0.220 |
Why?
|
Smoking Cessation | 1 | 2016 | 2084 | 0.220 |
Why?
|
Phenethylamines | 2 | 2001 | 95 | 0.220 |
Why?
|
Morphine | 6 | 2023 | 660 | 0.220 |
Why?
|
Periodicals as Topic | 2 | 2020 | 1462 | 0.220 |
Why?
|
Midazolam | 3 | 2003 | 267 | 0.210 |
Why?
|
Membrane Glycoproteins | 2 | 2004 | 3690 | 0.210 |
Why?
|
Rats, Sprague-Dawley | 9 | 2021 | 8105 | 0.210 |
Why?
|
Dopamine Plasma Membrane Transport Proteins | 3 | 2021 | 412 | 0.210 |
Why?
|
Pain | 3 | 2020 | 5076 | 0.210 |
Why?
|
Oxazines | 5 | 2004 | 358 | 0.200 |
Why?
|
Psychophysiology | 1 | 2002 | 136 | 0.200 |
Why?
|
Narcotics | 2 | 1996 | 333 | 0.200 |
Why?
|
Receptor, Serotonin, 5-HT2C | 2 | 2018 | 41 | 0.190 |
Why?
|
History, 20th Century | 4 | 2014 | 2761 | 0.190 |
Why?
|
Brain | 11 | 2024 | 27178 | 0.190 |
Why?
|
Drug Evaluation, Preclinical | 3 | 2019 | 1331 | 0.190 |
Why?
|
Monoamine Oxidase Inhibitors | 1 | 2001 | 152 | 0.180 |
Why?
|
Monoamine Oxidase | 1 | 2001 | 179 | 0.180 |
Why?
|
Scopolamine | 1 | 2021 | 92 | 0.180 |
Why?
|
Injections, Intramuscular | 5 | 2017 | 553 | 0.180 |
Why?
|
Levorphanol | 4 | 2010 | 9 | 0.180 |
Why?
|
Microdialysis | 3 | 2017 | 156 | 0.170 |
Why?
|
GABA Agonists | 1 | 2000 | 105 | 0.170 |
Why?
|
Callithrix | 2 | 2021 | 95 | 0.170 |
Why?
|
Adrenergic Uptake Inhibitors | 2 | 2015 | 187 | 0.170 |
Why?
|
Drug Design | 2 | 2014 | 1040 | 0.170 |
Why?
|
Hydromorphone | 1 | 2020 | 70 | 0.170 |
Why?
|
Receptors, GABA-A | 2 | 2001 | 623 | 0.170 |
Why?
|
Inflammation | 1 | 2019 | 10845 | 0.170 |
Why?
|
Behavioral Medicine | 1 | 2020 | 49 | 0.170 |
Why?
|
Structure-Activity Relationship | 7 | 2020 | 3053 | 0.170 |
Why?
|
Rodentia | 1 | 2021 | 262 | 0.160 |
Why?
|
Acetamides | 1 | 2001 | 260 | 0.160 |
Why?
|
Serotonin Plasma Membrane Transport Proteins | 2 | 2021 | 326 | 0.160 |
Why?
|
Benzopyrans | 1 | 2019 | 62 | 0.160 |
Why?
|
Scalp | 1 | 2022 | 388 | 0.160 |
Why?
|
Catalepsy | 2 | 1998 | 31 | 0.160 |
Why?
|
Antidepressive Agents | 2 | 2021 | 2902 | 0.160 |
Why?
|
Excitatory Amino Acid Antagonists | 1 | 2021 | 450 | 0.150 |
Why?
|
Hypercapnia | 1 | 2020 | 259 | 0.150 |
Why?
|
Evoked Potentials | 1 | 2024 | 1048 | 0.150 |
Why?
|
Antiemetics | 1 | 2020 | 185 | 0.150 |
Why?
|
Binding, Competitive | 7 | 2020 | 1140 | 0.150 |
Why?
|
Feeding Behavior | 5 | 2016 | 3210 | 0.150 |
Why?
|
Injections, Intravenous | 5 | 2017 | 1375 | 0.150 |
Why?
|
Self Stimulation | 1 | 2017 | 46 | 0.150 |
Why?
|
Neuropeptides | 1 | 2003 | 951 | 0.150 |
Why?
|
Caffeine | 1 | 2002 | 702 | 0.150 |
Why?
|
Primates | 4 | 2022 | 518 | 0.140 |
Why?
|
Monoacylglycerol Lipases | 1 | 2017 | 30 | 0.140 |
Why?
|
Acetylcysteine | 1 | 2019 | 262 | 0.140 |
Why?
|
Corpus Striatum | 1 | 2024 | 1218 | 0.140 |
Why?
|
Clozapine | 3 | 1997 | 509 | 0.140 |
Why?
|
Norepinephrine Plasma Membrane Transport Proteins | 1 | 2017 | 66 | 0.140 |
Why?
|
Ethylketocyclazocine | 2 | 2007 | 4 | 0.140 |
Why?
|
Histamine H1 Antagonists | 2 | 1988 | 100 | 0.140 |
Why?
|
Hallucinogens | 1 | 2021 | 211 | 0.140 |
Why?
|
Serotonin | 3 | 2017 | 1047 | 0.140 |
Why?
|
Excitatory Amino Acid Transporter 2 | 1 | 2018 | 88 | 0.140 |
Why?
|
Racemases and Epimerases | 1 | 2017 | 113 | 0.140 |
Why?
|
Drug Industry | 1 | 2003 | 791 | 0.140 |
Why?
|
Drug Substitution | 1 | 2019 | 292 | 0.140 |
Why?
|
Amidohydrolases | 1 | 2017 | 161 | 0.130 |
Why?
|
Analysis of Variance | 3 | 2015 | 6204 | 0.130 |
Why?
|
Pain Measurement | 2 | 2019 | 3559 | 0.130 |
Why?
|
Receptors, Cannabinoid | 1 | 2016 | 43 | 0.130 |
Why?
|
Recurrence | 3 | 2024 | 8506 | 0.130 |
Why?
|
Anabasine | 1 | 2016 | 6 | 0.130 |
Why?
|
Respiratory Insufficiency | 2 | 2022 | 1241 | 0.130 |
Why?
|
Drugs, Investigational | 1 | 2017 | 211 | 0.120 |
Why?
|
Analgesics | 3 | 2013 | 1057 | 0.120 |
Why?
|
Locomotion | 1 | 2018 | 384 | 0.120 |
Why?
|
Cotinine | 1 | 2016 | 206 | 0.120 |
Why?
|
Benzhydryl Compounds | 1 | 2022 | 939 | 0.120 |
Why?
|
Neurotransmitter Agents | 1 | 2019 | 663 | 0.120 |
Why?
|
Ketamine | 1 | 2021 | 525 | 0.120 |
Why?
|
Naphthalenes | 2 | 2013 | 197 | 0.120 |
Why?
|
Berberine | 1 | 2015 | 26 | 0.120 |
Why?
|
Photic Stimulation | 3 | 2021 | 1993 | 0.120 |
Why?
|
3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-Isomer | 3 | 2010 | 18 | 0.120 |
Why?
|
Humans | 45 | 2024 | 765823 | 0.110 |
Why?
|
Carbamates | 1 | 2016 | 191 | 0.110 |
Why?
|
Benzoxazines | 2 | 2013 | 320 | 0.110 |
Why?
|
Respiration | 3 | 1996 | 1652 | 0.110 |
Why?
|
Tetrahydroisoquinolines | 1 | 1994 | 81 | 0.110 |
Why?
|
Receptor, Cannabinoid, CB2 | 1 | 2013 | 48 | 0.110 |
Why?
|
Phencyclidine | 2 | 2021 | 59 | 0.110 |
Why?
|
Kynurenic Acid | 1 | 2013 | 44 | 0.110 |
Why?
|
Kinetics | 2 | 2018 | 6272 | 0.110 |
Why?
|
Benzodiazepines | 2 | 1999 | 1135 | 0.110 |
Why?
|
Nerve Tissue Proteins | 2 | 2017 | 4391 | 0.110 |
Why?
|
Hypnotics and Sedatives | 1 | 2001 | 1191 | 0.110 |
Why?
|
Gastrointestinal Tract | 1 | 2019 | 834 | 0.100 |
Why?
|
Appetite Stimulants | 1 | 2012 | 14 | 0.100 |
Why?
|
Chlorpheniramine | 2 | 1990 | 13 | 0.100 |
Why?
|
Drug Administration Schedule | 2 | 2016 | 4849 | 0.100 |
Why?
|
Stereoisomerism | 4 | 2006 | 613 | 0.100 |
Why?
|
Morpholines | 2 | 2013 | 577 | 0.100 |
Why?
|
Diagnosis, Computer-Assisted | 1 | 2017 | 698 | 0.100 |
Why?
|
Overnutrition | 1 | 2012 | 25 | 0.100 |
Why?
|
G Protein-Coupled Inwardly-Rectifying Potassium Channels | 1 | 2012 | 62 | 0.100 |
Why?
|
Diuresis | 1 | 2012 | 107 | 0.100 |
Why?
|
Pentobarbital | 2 | 2010 | 153 | 0.100 |
Why?
|
Receptors, N-Methyl-D-Aspartate | 1 | 2017 | 896 | 0.100 |
Why?
|
Butyrylcholinesterase | 1 | 2012 | 21 | 0.100 |
Why?
|
HEK293 Cells | 4 | 2016 | 4255 | 0.100 |
Why?
|
Antipsychotic Agents | 3 | 2008 | 3076 | 0.100 |
Why?
|
Memory, Short-Term | 2 | 2016 | 1002 | 0.100 |
Why?
|
Tritium | 1 | 2012 | 702 | 0.100 |
Why?
|
Appetite Depressants | 1 | 2012 | 108 | 0.100 |
Why?
|
Neural Pathways | 4 | 2024 | 3087 | 0.100 |
Why?
|
Basal Ganglia | 1 | 2015 | 549 | 0.100 |
Why?
|
Stress, Physiological | 1 | 2019 | 1405 | 0.090 |
Why?
|
Oxytocin | 1 | 2015 | 404 | 0.090 |
Why?
|
Haloperidol | 2 | 1994 | 394 | 0.090 |
Why?
|
CHO Cells | 3 | 2022 | 1372 | 0.090 |
Why?
|
Mecamylamine | 1 | 2010 | 27 | 0.090 |
Why?
|
Magnetic Resonance Imaging | 5 | 2024 | 36542 | 0.090 |
Why?
|
Physical Stimulation | 1 | 2012 | 513 | 0.090 |
Why?
|
Neurotransmitter Uptake Inhibitors | 2 | 1989 | 36 | 0.090 |
Why?
|
Benzodioxoles | 2 | 2021 | 80 | 0.090 |
Why?
|
Flumazenil | 2 | 2001 | 84 | 0.090 |
Why?
|
Naloxone | 3 | 1996 | 373 | 0.090 |
Why?
|
Learning | 2 | 2020 | 1754 | 0.090 |
Why?
|
Propiophenones | 3 | 2021 | 28 | 0.090 |
Why?
|
Benzomorphans | 2 | 1989 | 5 | 0.090 |
Why?
|
Desipramine | 3 | 2005 | 183 | 0.090 |
Why?
|
Gene Deletion | 1 | 2018 | 2667 | 0.090 |
Why?
|
Chlordiazepoxide | 2 | 1986 | 42 | 0.090 |
Why?
|
Protein Binding | 4 | 2021 | 9297 | 0.090 |
Why?
|
Benzamides | 1 | 2016 | 1376 | 0.090 |
Why?
|
Diazepam | 3 | 2003 | 215 | 0.080 |
Why?
|
Central Nervous System Agents | 1 | 2010 | 72 | 0.080 |
Why?
|
Cricetinae | 3 | 2022 | 2412 | 0.080 |
Why?
|
Body Temperature | 1 | 2012 | 781 | 0.080 |
Why?
|
Female | 25 | 2024 | 396050 | 0.080 |
Why?
|
Albumins | 1 | 2012 | 577 | 0.080 |
Why?
|
Pyrimidines | 1 | 2001 | 3047 | 0.080 |
Why?
|
Kwashiorkor | 1 | 1988 | 24 | 0.080 |
Why?
|
Mice | 10 | 2022 | 81788 | 0.080 |
Why?
|
Social Behavior | 1 | 2015 | 1143 | 0.080 |
Why?
|
Cholinesterase Inhibitors | 1 | 2010 | 241 | 0.080 |
Why?
|
Genetics, Behavioral | 1 | 2008 | 52 | 0.080 |
Why?
|
Norepinephrine | 2 | 2017 | 898 | 0.080 |
Why?
|
Quinoxalines | 1 | 2010 | 296 | 0.080 |
Why?
|
Carbolines | 2 | 2001 | 288 | 0.080 |
Why?
|
Avoidance Learning | 1 | 2010 | 248 | 0.070 |
Why?
|
Extracellular Space | 1 | 2010 | 564 | 0.070 |
Why?
|
Haplorhini | 1 | 2008 | 520 | 0.070 |
Why?
|
Cognition Disorders | 1 | 2022 | 3966 | 0.070 |
Why?
|
Hot Temperature | 1 | 2014 | 1433 | 0.070 |
Why?
|
Extinction, Psychological | 2 | 2019 | 367 | 0.070 |
Why?
|
Enzyme Inhibitors | 1 | 2017 | 3716 | 0.070 |
Why?
|
Confidence Intervals | 1 | 2012 | 2914 | 0.070 |
Why?
|
Cyclazocine | 1 | 1985 | 10 | 0.060 |
Why?
|
Water | 1 | 2012 | 1417 | 0.060 |
Why?
|
Generalization, Stimulus | 1 | 2005 | 13 | 0.060 |
Why?
|
Phenanthridines | 2 | 1996 | 49 | 0.060 |
Why?
|
Molecular Structure | 3 | 2016 | 1886 | 0.060 |
Why?
|
Nalorphine | 1 | 1985 | 5 | 0.060 |
Why?
|
Attention | 1 | 2016 | 2415 | 0.060 |
Why?
|
History, 21st Century | 1 | 2011 | 1573 | 0.060 |
Why?
|
Morphine Dependence | 1 | 1985 | 27 | 0.060 |
Why?
|
GABA Modulators | 2 | 2003 | 108 | 0.060 |
Why?
|
Heart Rate | 3 | 2021 | 4202 | 0.060 |
Why?
|
Vesicular Biogenic Amine Transport Proteins | 1 | 2003 | 9 | 0.060 |
Why?
|
Association Learning | 1 | 2005 | 219 | 0.060 |
Why?
|
Chlorides | 1 | 1986 | 666 | 0.050 |
Why?
|
Lithium | 1 | 1986 | 599 | 0.050 |
Why?
|
Mental Disorders | 2 | 2019 | 6872 | 0.050 |
Why?
|
Nanoparticles | 1 | 2015 | 1967 | 0.050 |
Why?
|
Neurons | 2 | 2024 | 9521 | 0.050 |
Why?
|
Conditioning, Classical | 1 | 2005 | 368 | 0.050 |
Why?
|
Depressive Disorder, Major | 1 | 2020 | 4805 | 0.050 |
Why?
|
Probability Learning | 1 | 2021 | 23 | 0.050 |
Why?
|
Sodium Chloride | 1 | 2003 | 577 | 0.050 |
Why?
|
GABA Antagonists | 1 | 2001 | 120 | 0.050 |
Why?
|
Pentanones | 1 | 2021 | 12 | 0.050 |
Why?
|
Time Factors | 4 | 2015 | 40109 | 0.050 |
Why?
|
Tremor | 1 | 2022 | 197 | 0.040 |
Why?
|
Citalopram | 1 | 2003 | 402 | 0.040 |
Why?
|
Salivation | 1 | 2020 | 22 | 0.040 |
Why?
|
Receptors, Dopamine | 2 | 1991 | 291 | 0.040 |
Why?
|
Treatment Outcome | 3 | 2018 | 65223 | 0.040 |
Why?
|
Receptors, Muscarinic | 1 | 2021 | 156 | 0.040 |
Why?
|
Species Specificity | 1 | 2024 | 2406 | 0.040 |
Why?
|
Tetrahydronaphthalenes | 1 | 2000 | 84 | 0.040 |
Why?
|
Benzodiazepinones | 1 | 1999 | 50 | 0.040 |
Why?
|
Swimming | 1 | 2021 | 212 | 0.040 |
Why?
|
Cues | 2 | 2016 | 877 | 0.040 |
Why?
|
GABA-A Receptor Antagonists | 1 | 1999 | 57 | 0.040 |
Why?
|
Pharmacological Phenomena | 1 | 2019 | 10 | 0.040 |
Why?
|
Behavioral Sciences | 1 | 2019 | 28 | 0.040 |
Why?
|
Cricetulus | 1 | 2021 | 806 | 0.040 |
Why?
|
Rest | 1 | 2024 | 940 | 0.040 |
Why?
|
Stress, Psychological | 1 | 2014 | 4528 | 0.040 |
Why?
|
Schizophrenia | 1 | 2017 | 6970 | 0.040 |
Why?
|
Sleep, REM | 1 | 2022 | 593 | 0.040 |
Why?
|
Evoked Potentials, Visual | 1 | 2021 | 419 | 0.040 |
Why?
|
Ergolines | 1 | 1998 | 55 | 0.040 |
Why?
|
Adrenergic Agents | 1 | 1998 | 71 | 0.040 |
Why?
|
Drug Agonism | 1 | 2017 | 2 | 0.040 |
Why?
|
Free Radical Scavengers | 1 | 2019 | 213 | 0.040 |
Why?
|
Drug Antagonism | 1 | 2017 | 50 | 0.040 |
Why?
|
Infusions, Subcutaneous | 1 | 2017 | 43 | 0.040 |
Why?
|
Binding Sites | 3 | 1999 | 5999 | 0.040 |
Why?
|
United States | 3 | 2014 | 72896 | 0.040 |
Why?
|
Serotonin 5-HT2 Receptor Agonists | 1 | 2017 | 30 | 0.040 |
Why?
|
Glycerides | 1 | 2017 | 67 | 0.040 |
Why?
|
Models, Molecular | 2 | 2020 | 5377 | 0.030 |
Why?
|
Brain Mapping | 2 | 2024 | 6598 | 0.030 |
Why?
|
Mice, 129 Strain | 1 | 2018 | 369 | 0.030 |
Why?
|
Imidazoles | 1 | 2003 | 1164 | 0.030 |
Why?
|
Vomiting | 1 | 2020 | 645 | 0.030 |
Why?
|
Bupropion | 2 | 1989 | 303 | 0.030 |
Why?
|
Task Performance and Analysis | 1 | 2021 | 771 | 0.030 |
Why?
|
Thiophenes | 1 | 2001 | 570 | 0.030 |
Why?
|
Psychiatry | 1 | 2008 | 1715 | 0.030 |
Why?
|
Codeine | 1 | 1996 | 52 | 0.030 |
Why?
|
Arousal | 1 | 2022 | 1175 | 0.030 |
Why?
|
Executive Function | 1 | 2024 | 1391 | 0.030 |
Why?
|
Myocardium | 1 | 1988 | 4763 | 0.030 |
Why?
|
Rats, Wistar | 1 | 1999 | 1884 | 0.030 |
Why?
|
Receptors, Drug | 2 | 1992 | 156 | 0.030 |
Why?
|
Pyrroles | 1 | 2001 | 1119 | 0.030 |
Why?
|
Models, Animal | 1 | 2021 | 2120 | 0.030 |
Why?
|
Gyrus Cinguli | 1 | 2020 | 1116 | 0.030 |
Why?
|
Serine | 1 | 2017 | 824 | 0.030 |
Why?
|
Stimulation, Chemical | 1 | 1993 | 303 | 0.030 |
Why?
|
Flupenthixol | 1 | 1993 | 11 | 0.030 |
Why?
|
Cannabis | 1 | 2020 | 446 | 0.030 |
Why?
|
Salicylamides | 1 | 1993 | 31 | 0.030 |
Why?
|
Carbon Dioxide | 2 | 1996 | 1137 | 0.030 |
Why?
|
Autoantigens | 1 | 2017 | 883 | 0.030 |
Why?
|
Protein Isoforms | 1 | 2018 | 1717 | 0.030 |
Why?
|
Anticonvulsants | 1 | 2003 | 1919 | 0.030 |
Why?
|
Isoquinolines | 1 | 1994 | 350 | 0.030 |
Why?
|
Mice, Knockout | 2 | 2018 | 14445 | 0.020 |
Why?
|
Drug Therapy | 1 | 2015 | 504 | 0.020 |
Why?
|
Nerve Net | 1 | 2024 | 2310 | 0.020 |
Why?
|
Glutamic Acid | 1 | 2017 | 1180 | 0.020 |
Why?
|
Marijuana Abuse | 1 | 2016 | 410 | 0.020 |
Why?
|
Evaluation Studies as Topic | 1 | 1994 | 1606 | 0.020 |
Why?
|
Indans | 1 | 1992 | 92 | 0.020 |
Why?
|
Analgesia | 1 | 1996 | 461 | 0.020 |
Why?
|
Biocatalysis | 1 | 2012 | 167 | 0.020 |
Why?
|
Radioligand Assay | 1 | 1991 | 364 | 0.020 |
Why?
|
gamma-Aminobutyric Acid | 1 | 2017 | 1139 | 0.020 |
Why?
|
Hemodynamics | 1 | 2002 | 4188 | 0.020 |
Why?
|
Half-Life | 1 | 2012 | 645 | 0.020 |
Why?
|
Personality | 1 | 2014 | 560 | 0.020 |
Why?
|
Interpersonal Relations | 1 | 2018 | 1433 | 0.020 |
Why?
|
Pyrilamine | 1 | 1990 | 13 | 0.020 |
Why?
|
Posture | 1 | 1994 | 955 | 0.020 |
Why?
|
Mazindol | 1 | 1989 | 13 | 0.020 |
Why?
|
Nomifensine | 1 | 1989 | 14 | 0.020 |
Why?
|
Astrocytes | 1 | 2018 | 1345 | 0.020 |
Why?
|
Attention Deficit Disorder with Hyperactivity | 1 | 2005 | 3718 | 0.020 |
Why?
|
Fear | 1 | 2018 | 1496 | 0.020 |
Why?
|
Respiration, Artificial | 1 | 2020 | 2711 | 0.020 |
Why?
|
Cyproheptadine | 1 | 1988 | 21 | 0.020 |
Why?
|
Head | 1 | 1994 | 925 | 0.020 |
Why?
|
Putamen | 1 | 1989 | 289 | 0.020 |
Why?
|
Carrier Proteins | 2 | 1992 | 4911 | 0.020 |
Why?
|
Depression | 2 | 2021 | 8224 | 0.020 |
Why?
|
Caudate Nucleus | 1 | 1989 | 388 | 0.020 |
Why?
|
Double-Blind Method | 1 | 2022 | 12421 | 0.020 |
Why?
|
Gene Expression Profiling | 1 | 2024 | 9520 | 0.020 |
Why?
|
Movement | 1 | 1994 | 1460 | 0.020 |
Why?
|
Heart Septum | 1 | 1988 | 303 | 0.020 |
Why?
|
Sex Factors | 1 | 2021 | 10607 | 0.020 |
Why?
|
Antibody Formation | 1 | 2012 | 1391 | 0.020 |
Why?
|
Secondary Prevention | 1 | 2013 | 1471 | 0.020 |
Why?
|
Tripelennamine | 1 | 1986 | 6 | 0.020 |
Why?
|
Promethazine | 1 | 1986 | 29 | 0.020 |
Why?
|
Cimetidine | 1 | 1986 | 76 | 0.020 |
Why?
|
Indoles | 1 | 1995 | 1832 | 0.020 |
Why?
|
Molecular Biology | 1 | 2010 | 574 | 0.020 |
Why?
|
Child Behavior | 1 | 2012 | 864 | 0.020 |
Why?
|
Diphenhydramine | 1 | 1986 | 61 | 0.020 |
Why?
|
Lithium Chloride | 1 | 1986 | 82 | 0.020 |
Why?
|
Phenazocine | 1 | 1985 | 7 | 0.020 |
Why?
|
Thiazoles | 1 | 2013 | 1529 | 0.020 |
Why?
|
Sleep | 1 | 2022 | 4819 | 0.020 |
Why?
|
Hippocampus | 1 | 2018 | 3774 | 0.020 |
Why?
|
Propylamines | 1 | 2005 | 161 | 0.010 |
Why?
|
Infusion Pumps | 1 | 2005 | 163 | 0.010 |
Why?
|
Adolescent Behavior | 1 | 2012 | 1185 | 0.010 |
Why?
|
Sulfonamides | 1 | 2013 | 1981 | 0.010 |
Why?
|
Nordazepam | 1 | 2003 | 5 | 0.010 |
Why?
|
Anorexia Nervosa | 1 | 2012 | 1328 | 0.010 |
Why?
|
Myocardial Contraction | 1 | 1988 | 1516 | 0.010 |
Why?
|
Reproducibility of Results | 1 | 2021 | 20131 | 0.010 |
Why?
|
Comorbidity | 1 | 2017 | 10570 | 0.010 |
Why?
|
Neuronal Plasticity | 1 | 2010 | 1444 | 0.010 |
Why?
|
Adult | 3 | 2024 | 223055 | 0.010 |
Why?
|
Food Deprivation | 1 | 1981 | 114 | 0.010 |
Why?
|
Epigenesis, Genetic | 1 | 2014 | 3815 | 0.010 |
Why?
|
Combined Modality Therapy | 1 | 2012 | 8529 | 0.010 |
Why?
|
Phenotype | 1 | 2018 | 16706 | 0.010 |
Why?
|
Mice, Inbred C57BL | 1 | 2018 | 22323 | 0.010 |
Why?
|
Chromatography, High Pressure Liquid | 1 | 2003 | 1527 | 0.010 |
Why?
|
Blood Pressure | 2 | 2007 | 8532 | 0.010 |
Why?
|
Young Adult | 1 | 2024 | 59849 | 0.010 |
Why?
|
Stress Disorders, Post-Traumatic | 1 | 2014 | 4627 | 0.010 |
Why?
|
Heart Ventricles | 1 | 1988 | 3832 | 0.010 |
Why?
|
Echocardiography | 1 | 1988 | 5042 | 0.010 |
Why?
|
Diet | 1 | 2012 | 8085 | 0.010 |
Why?
|
Cyclic AMP | 1 | 1997 | 1467 | 0.010 |
Why?
|
Levodopa | 1 | 1991 | 221 | 0.010 |
Why?
|
Macaca fascicularis | 1 | 1989 | 907 | 0.000 |
Why?
|
Infant | 1 | 1988 | 36375 | 0.000 |
Why?
|
Child, Preschool | 1 | 1988 | 42478 | 0.000 |
Why?
|
Child | 1 | 2012 | 80509 | 0.000 |
Why?
|
Adolescent | 1 | 2012 | 88794 | 0.000 |
Why?
|